These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 20329491)

  • 1. Structural and cellular changes in canine myxomatous mitral valve disease: an image analysis study.
    Han RI; Black A; Culshaw G; French AT; Corcoran BM
    J Heart Valve Dis; 2010 Jan; 19(1):60-70. PubMed ID: 20329491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of myofibroblasts, smooth muscle-like cells, macrophages, and mast cells in mitral valve leaflets of dogs with myxomatous mitral valve disease.
    Han RI; Black A; Culshaw GJ; French AT; Else RW; Corcoran BM
    Am J Vet Res; 2008 Jun; 69(6):763-9. PubMed ID: 18518656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial cells from dogs with naturally occurring myxomatous mitral valve disease undergo phenotype transformation.
    Disatian S; Ehrhart EJ; Zimmerman S; Orton EC
    J Heart Valve Dis; 2008 Jul; 17(4):402-11; discussion 412. PubMed ID: 18751470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tryptophan hydroxylase 1 expression is increased in phenotype-altered canine and human degenerative myxomatous mitral valves.
    Disatian S; Lacerda C; Orton EC
    J Heart Valve Dis; 2010 Jan; 19(1):71-8. PubMed ID: 20329492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell maceration scanning electron microscopy and computer-derived porosity measurements in assessment of connective tissue microstructure changes in the canine myxomatous mitral valve.
    Han RI; Impoco G; Culshaw G; French AT; Black A; Corcoran BM
    Vet J; 2013 Aug; 197(2):502-5. PubMed ID: 23465749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of innervation of the mitral valves and the effects of myxomatous degeneration in dogs.
    Culshaw GJ; French AT; Han RI; Black A; Pearson GT; Corcoran BM
    Am J Vet Res; 2010 Feb; 71(2):194-202. PubMed ID: 20113227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arteriosclerotic changes in the myocardium, lung, and kidney in dogs with chronic congestive heart failure and myxomatous mitral valve disease.
    Falk T; Jönsson L; Olsen LH; Pedersen HD
    Cardiovasc Pathol; 2006; 15(4):185-93. PubMed ID: 16844549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cellular changes in Cavalier King Charles spaniel and mixed breed dogs with myxomatous mitral valve disease.
    Lu CC; Liu MM; Culshaw G; French A; Corcoran B
    J Vet Cardiol; 2016 Jun; 18(2):100-9. PubMed ID: 26860643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis and abundance of Bcl-2 family and transforming growth factor β1 signaling proteins in canine myxomatous mitral valves.
    Surachetpong S; Jiranantasak T; Rungsipipat A; Orton EC
    J Vet Cardiol; 2013 Sep; 15(3):171-80. PubMed ID: 23816827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of myxomatous mitral valve disease in the dog.
    Fox PR
    J Vet Cardiol; 2012 Mar; 14(1):103-26. PubMed ID: 22386587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine serotonin and transforming growth factor beta 1 signaling mediates spontaneous myxomatous mitral valve disease.
    Disatian S; Orton EC
    J Heart Valve Dis; 2009 Jan; 18(1):44-51. PubMed ID: 19301552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological changes to endothelial and interstitial cells and to the extra-cellular matrix in canine myxomatous mitral valve disease (endocardiosis).
    Han RI; Clark CH; Black A; French A; Culshaw GJ; Kempson SA; Corcoran BM
    Vet J; 2013 Aug; 197(2):388-94. PubMed ID: 23465752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathology, protein expression and signaling in myxomatous mitral valve degeneration: comparison of dogs and humans.
    Aupperle H; Disatian S
    J Vet Cardiol; 2012 Mar; 14(1):59-71. PubMed ID: 22364722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of signal analysis of heart sounds and murmurs to assess severity of mitral valve regurgitation attributable to myxomatous mitral valve disease in dogs.
    Ljungvall I; Ahlstrom C; Höglund K; Hult P; Kvart C; Borgarelli M; Ask P; Häggström J
    Am J Vet Res; 2009 May; 70(5):604-13. PubMed ID: 19405899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four decades of experience with mitral valve repair: analysis of differential indications, technical evolution, and long-term outcome.
    DiBardino DJ; ElBardissi AW; McClure RS; Razo-Vasquez OA; Kelly NE; Cohn LH
    J Thorac Cardiovasc Surg; 2010 Jan; 139(1):76-83; discussion 83-4. PubMed ID: 19931098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased NADPH-diaphorase activity in canine myxomatous mitral valve leaflets.
    Olsen LH; Mortensen K; Martinussen T; Larsson LI; Baandrup U; Pedersen HD
    J Comp Pathol; 2003; 129(2-3):120-30. PubMed ID: 12921717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanical properties of myxomatous mitral valves.
    Barber JE; Kasper FK; Ratliff NB; Cosgrove DM; Griffin BP; Vesely I
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):955-62. PubMed ID: 11689801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of systolic anterior motion after repair of the severely myxomatous mitral valve with an anterior leaflet valvuloplasty.
    Quigley RL
    Ann Thorac Surg; 2005 Jul; 80(1):179-82; discussion 182. PubMed ID: 15975363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multifactorial etiology of mitral valve prolapse, a new entity of postinflammatory mitral valve prolapse.
    Tomaru T
    Herz; 1988 Oct; 13(5):271-6. PubMed ID: 2460397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased endothelin-receptor density in myxomatous canine mitral valve leaflets.
    Mow T; Pedersen HD
    J Cardiovasc Pharmacol; 1999 Aug; 34(2):254-60. PubMed ID: 10445677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.